Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Deep Track Capital, LP
Form 13F · Q2 2026

Deep Track Capital, LP

CIK 1856083申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$68.7亿
申報組合市值
67
持倉數量
12
Quarters on record
Top 50
持倉數量

Deep Track Capital, LP——持倉

共 67 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1GH Guardant Health Inc3.4M+1.6%$5.1亿7.4%
2IMVT Immunovant Inc9.3M−19.0%$3.6亿5.2%
3GPCR Structure Therapeutics Inc4.7M+10.8%$2.5亿3.7%
4PCVX Vaxcyte Inc4.3M+0.0%$2.5亿3.6%
5ALNY Alnylam Pharmaceuticals Inc825,000—$2.5亿3.6%
6MANE Veradermics Inc2.0M+300.0%$2.5亿3.6%
7TARS Tarsus Pharmaceuticals Inc3.7M+1.9%$2.3亿3.4%
8NUVALENT INC Nuvalent Inc1.8M+29.6%$2.2亿3.2%
9ALKS Alkermes Plc4.0M+11.4%$2.1亿3.1%
10OCUL Ocular Therapeutix Inc19.7M+0.0%$1.9亿2.8%
11BMRN Biomarin Pharmaceutical Inc3.3M+187.6%$1.9亿2.8%
12NRIX Nurix Therapeutics Inc7.7M+21.9%$1.9亿2.7%
13ORKA Oruka Therapeutics Inc1.9M−5.3%$1.8亿2.7%
14ALMS Alumis Inc6.3M−6.3%$1.8亿2.6%
15IONS Ionis Pharmaceuticals Inc2.2M+12.8%$1.7亿2.5%
16CMPS Compass Pathways Plc12.2M+0.0%$1.7亿2.5%
17VERA Vera Therapeutics Inc4.0M−2.6%$1.7亿2.5%
18AXSM Axsome Therapeutics Inc.700,000−36.4%$1.7亿2.5%
19GMAB Genmab A/S5.7M+54.2%$1.6亿2.3%
20MLTX Moonlake Immunotherapeutics7.0M+9.2%$1.4亿2.0%
21COAG Hemab Therapeutics Hldgs Inc3.6M—$1.3亿1.9%
22TNGX Tango Therapeutics Inc4.2M+52.7%$1.3亿1.9%
23DFTX Definium Therapeutics Inc2.8M−8.3%$1.3亿1.9%
24GRAL Grail Inc1.8M+6.5%$1.3亿1.8%
25BCAX Bicara Therapeutics Inc4.1M+0.9%$1.2亿1.8%
26MAZE Maze Therapeutics Inc3.7M+7.3%$1.1亿1.6%
27CLDX Celldex Therapeutics Inc New2.9M+128.9%$1.1亿1.6%
28LBRX Lb Pharmaceuticals Inc3.4M+0.0%$1.1亿1.6%
29MBX Mbx Biosciences Inc1.7M−37.2%$9564万1.4%
30GHRS Gh Research Plc3.3M—$8960万1.3%
31COGT Cogent Biosciences Inc2.0M+100.0%$7740万1.1%
32ATAIBECKLEY INC Ataibeckley Inc14.4M+20.1%$7598万1.1%
33UTHR United Therapeutics Corp Del123,616—$6698万1.0%
34AVTX Avalo Therapeutics Inc3.6M—$6671万1.0%
35VRDN Viridian Therapeutics Inc3.6M+157.7%$6600万1.0%
36CYTK Cytokinetics Inc700,000−49.1%$5963万0.9%
37ALT Altimmune Inc19.2M—$5852万0.9%
38PSNL Personalis Inc4.0M+33.3%$5360万0.8%
39ACRS Aclaris Therapeutics Inc9.3M+0.0%$4944万0.7%
40CRMD Cormedix Inc6.3M+0.0%$4925万0.7%
41WGS Genedx Holdings Corp700,000—$4806万0.7%
42HROW Harrow Inc969,000—$4115万0.6%
43CRVS Corvus Pharmaceuticals Inc2.5M+0.0%$3723万0.5%
44SLDB Solid Biosciences Inc3.6M+0.0%$3561万0.5%
45BEAM Beam Therapeutics Inc1.0M+21.8%$3432万0.5%
46DYN Dyne Therapeutics Inc1.5M−25.0%$3332万0.5%
47IMMX Immix Biopharma Inc2.8M—$2861万0.4%
48XFOR X4 Pharmaceuticals Inc5.9M−7.3%$2745万0.4%
49STTK Shattuck Labs Inc3.7M—$2572万0.4%
50MNKD Mannkind Corp6.0M—$2556万0.4%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。